The report will be delivered in 2-3 business days.

Antibody Drug Conjugates Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : October 2019 | SKU CODE : 7197 | Format :


The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates (ADCs). Antibody-drug conjugates (ADCs) are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

The global antibody drug conjugates market was valued at about $1.89 billion in 2018 and is expected to grow to $4.98 billion at a CAGR of 27.4% through 2022.

North America was the largest region in the antibody drug conjugates market in 2018. This region is expected to remain the largest during the next five years. The antibody drug conjugates market in the same region is forecasted to register the highest CAGR during 2018-2023.

The antibody drug conjugates market is being driven by rising incidences of cancer globally. The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to the World Health Organization, cancer is responsible for an estimated 9.6 million deaths in 2018. The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040. The rising incidences of cancer are expected to increase the demand for antibody drug conjugates driving market growth.

The challenges involved in the manufacturing of ADC's is acting as a restraint on the antibody drug conjugates market. ADC manufacturing facilities require high capital investment and extensive specialized training for operators. ADC process development is complicated as it requires optimization of additional process steps that are not present in conventional monoclonal antibodies manufacturing such as the antibody-drug conjugation reaction and subsequent drug substance purification. Also, antibody drug conjugates must be manufactured in aseptic environments and operating personnel should be protected from the highly toxic drug compounds, therby presenting operational difficulties.

Manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business. For instance, in March 2019, Astrazeneca entered into a global development and commercialization collaboration agreement with Daiichi Sankyo Company for the proprietary antibody drug conjugate trastuzumab deruxtecan (DS-8201). In April 2019, Shanghai Miracogen entered into an agreement with Netherlands based Synaffix to use its tools for building antibody drug conjugates. According to the deal, Miracogen is licensing two platforms from Synaffix which is expected to boost its product pipeline.

Manufacturers of antibody drug conjugates are monitored by various regulatory bodies such as the Food and Drug Administration in the USA. In the USA, there is no specific regulatory guidance to industry on ADC development and the FDA follows existing guidelines for small drugs and monoclonal antibodies to regulate ADC. The product quality offices at FDA such as the Office of Biotechnology Products (OBP)/Office of Pharmaceutical Quality primarily focus on the manufacturing of the antibody component of the ADC and the control strategy for the antibody intermediate, as well as for the drug substance (DS) and drug product (DP). Small molecule review groups in the Office of Pharmaceutical Quality bear primary responsibility for review of the adequacy of the payload and linker, conjugation reaction and aspects of the control strategy.

Major players in the market are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics, Inc., Oxford BioTherapeutics

    1. Executive Summary

    2. Antibody Drug Conjugates Market Characteristics

    3. Antibody Drug Conjugates Market Size And Growth

    3.1. Global Antibody Drug Conjugates Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Antibody Drug Conjugates Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Antibody Drug Conjugates Market Segmentation

    4.1. Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Monoclonal Antibodies

    Linker

    Drug/Toxin

    Others

    4.2. Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Blood Cancer

    Breast Cancer

    Ovarian Cancer

    Lung Cancer

    Brain Tumor

    Others

    4.3. Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Adcertis

    Kadcyla

    Others

    4.4. Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Immunogen Technology

    Seattle Genetics Technology

    Immunomedics Technology

    Others

    4.5. Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Hospital

    Clinics

    Others

    5. Antibody Drug Conjugates Market Regional And Country Analysis

    5.1. Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Antibody Drug Conjugates Market  

    6.1. Asia-Pacific Antibody Drug Conjugates Market Overview  

    6.2. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Antibody Drug Conjugates Market  

    7.1. China Antibody Drug Conjugates Market Overview  

    7.2. China Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Antibody Drug Conjugates Market  

    8.1. India Antibody Drug Conjugates Market Overview  

    8.2. India Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Antibody Drug Conjugates Market  

    9.1. Japan Antibody Drug Conjugates Market Overview  

    9.2. Japan Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Antibody Drug Conjugates Market  

    10.1. Australia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Antibody Drug Conjugates Market  

    11.1. Indonesia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Antibody Drug Conjugates Market  

    12.1. South Korea Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Antibody Drug Conjugates Market  

    13.1. Western Europe Antibody Drug Conjugates Market Overview

    13.2. Western Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Antibody Drug Conjugates Market  

    14.1. UK Antibody Drug Conjugates Market Overview

    14.2. UK Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Antibody Drug Conjugates Market  

    15.1. Germany Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Antibody Drug Conjugates Market  

    16.5. France Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Antibody Drug Conjugates Market  

    17.1. Eastern Europe Antibody Drug Conjugates Market Overview

    17.2. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Antibody Drug Conjugates Market  

    18.1. Russia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Antibody Drug Conjugates Market  

    19.1. North America Antibody Drug Conjugates Market Overview

    19.2. North America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Antibody Drug Conjugates Market  

    20.1. USA Antibody Drug Conjugates Market Overview

    20.2. USA Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Antibody Drug Conjugates Market  

    21.1. South America Antibody Drug Conjugates Market Overview

    21.2. South America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Antibody Drug Conjugates Market  

    22.1. Brazil Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Antibody Drug Conjugates Market  

    23.1. Middle East Antibody Drug Conjugates Market Overview

    23.2. Middle East Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Antibody Drug Conjugates Market  

    24.1. Africa Antibody Drug Conjugates Market Overview

    24.2. Africa Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles

    25.1. Antibody Drug Conjugates Market Competitive Landscape

    25.2. Antibody Drug Conjugates Market Company Profiles

    25.2.1. Bayer AG

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Concortis Biotherapeutics

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. F. Hoffman-La Roche Ltd.

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Immunomedics, Inc.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Oxford BioTherapeutics

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market

    27. Antibody Drug Conjugates Market Trends And Strategies

    28. Product Pipeline Analysis

    29. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: China, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: China, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: India, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: India, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Japan, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Japan, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Australia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Australia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Indonesia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: Indonesia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: South Korea, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: South Korea, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Western Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: Western Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: UK, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: UK, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: Germany, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: Germany, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: France, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: France, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Russia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: Russia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: North America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: North America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: USA, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: USA, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: South America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: South America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Brazil, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Brazil, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Middle East, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Middle East, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: Africa, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 66: Africa, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 67: Bayer AG Financial Performance
  • Table 68: Concortis Biotherapeutics Financial Performance
  • Table 69: F. Hoffman-La Roche Ltd. Financial Performance
  • Table 70: Immunomedics, Inc. Financial Performance
  • Table 71: Oxford BioTherapeutics Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: Asia-Pacific, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: China, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: China, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: India, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: India, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Japan, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Japan, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Australia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Australia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Indonesia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: Indonesia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: South Korea, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: South Korea, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Western Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: Western Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: UK, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: UK, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: Germany, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: Germany, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: France, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: France, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Eastern Europe, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Russia, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: Russia, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: North America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: North America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: USA, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: USA, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: South America, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: South America, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Brazil, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Brazil, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Middle East, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Middle East, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: Africa, Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 66: Africa, Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 67: Bayer AG Financial Performance
  • Figure 68: Concortis Biotherapeutics Financial Performance
  • Figure 69: F. Hoffman-La Roche Ltd. Financial Performance
  • Figure 70: Immunomedics, Inc. Financial Performance
  • Figure 71: Oxford BioTherapeutics Financial Performance
Research And Development Initiatives Taken In The Anti-Infective Drugs Market
Research Initiatives And Funding And Demand For New Medicines For Drug-Resistant Infections In The Anti-Infective Drugs Industry
Global Biologics Market, Opportunities And Strategies Market | Characteristics, Forecast Size, Trends
Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions and By Key Players - Global Forecast To 2021
View Report
Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
View Report
Cardiovascular Drugs Global Market Report 2019
View Report
Dermatology Drugs Global Market Report 2019
View Report
Gastrointestinal Drugs Global Market Report 2019
View Report
Hematology Drugs Global Market Report 2019
View Report
Metabolic Disorders Drugs Global Market Report 2019
View Report
Musculoskeletal Disorders Drugs Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)